Ирска - Енглески - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - valaciclovir hydrochloride monohydrate - film coated tablet - 500 milligram

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - valaciclovir hydrochloride monohydrate - film coated tablet - 500 milligram

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 1223.4 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with vaciclor, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 1223.4 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with vaciclor, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 305.85 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with vaciclor, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - valaciclovir hydrochloride -

Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

daiichi sankyo espha co., ltd. - valaciclovir hydrochloride - white to slightly yellowish white tablet, major axis 18.5 mm, minor axis 7.5 mm, thickness 6.2 mm

Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

kyosomirai pharma co., ltd. - valaciclovir hydrochloride - white to faintly yellowish white tablet, major axis: approx. 18.5 mm, minor axis: approx. 7.5 mm, thickness: approx. 6.2 mm

Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - valaciclovir hydrochloride - white to faintly yellowish white tablet, major axis: 17.3 mm, minor axis: 8.1 mm, thickness: 6.5 mm

Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

nippon-chemiphar co.,ltd - valaciclovir hydrochloride - white to faintly yellowish white tablet, major axis : 18.5 mm, minor axis : 7.5 mm, thickness: 6.2 mm